The Effect of Methylated Vitamin B Complex on Depression
1 other identifier
interventional
60
1 country
1
Brief Summary
The proposed study is a 60-day, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of a methylated vitamin B complex nutritional supplement (Max Stress B™) for improving depressive and anxiety symptoms according to the Beck Depression and Anxiety Inventories, respectively, in 60 patients (18+ years of age) diagnosed with major depression or other forms of depressive disorders and an elevated level of homocysteine (\> 10 µmol/L) at baseline. Secondary outcomes will include anthropometrics for body composition, blood pressure and pulse, level of physical activity, dietary intake, and quality of life. Participants will be assessed at baseline and 30 and 60 days. The study will consist of two treatment arms: (a) vitamin B complex nutritional supplement and (b) placebo. The information obtained in this study will help in determining the efficacy of using nutritional supplements for improving the outcomes of people with depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Jan 2011
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 21, 2012
CompletedFirst Posted
Study publicly available on registry
August 24, 2012
CompletedAugust 6, 2014
August 1, 2014
9 months
August 21, 2012
August 4, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Depression level
Assessed by the Beck Depression Inventory II, the Beck Anxiety Inventory, SF-36v2™ Health Survey, physiological and anthropometric measures Because item 9 of the Beck Depression Inventory inquires about "Suicidal thoughts or wishes," we will immediately notify the attending physician in the Crisis facility of UM/JMH if a subject responds affirmatively to this question, which may be indicative of suicidal ideation (SI).
2 months
Study Arms (2)
Placebo Max Stress B
PLACEBO COMPARATORoil/water emulsion with food coloring to simulate actual product
Max Stress B
EXPERIMENTALwhole-nutrient natural source extract from probiotic colonies that contains vitamins B1, B2, B5, B6, B12, and folate, PABA, biotin, inositol, purified water and certified organic alcohol.
Interventions
Participants are to mix one vial per day of either placebo or actual supplement in 1 liter of water and drink over the course of the day
Eligibility Criteria
You may qualify if:
- Men and women ages 18 years and over.
- Individuals with a diagnosed type or form of depression.
- An elevated level of homocysteine (\> 10 µmol/L) at screening.
- Interest in participating in a novel nutritional supplement program.
- Willingness to follow recommendations, including going off of all medication for depression 2 weeks before starting vitamin B complex regimen.
You may not qualify if:
- Excluded in any of the above criteria are not met.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Miamilead
- Premier Research Labscollaborator
Study Sites (1)
University of Miami CRB
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John E Lewis, PhD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 21, 2012
First Posted
August 24, 2012
Study Start
January 1, 2011
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
August 6, 2014
Record last verified: 2014-08